CRISPR‐Cas9 has enabled scientists to repair mutations in the cftr locus that causes cystic fibrosis in cultured intestinal stem cells from cystic fibrosis patients (Hille and Charpentier, 2016; Schwank et al., 2013). Here, CFTR is linked to cystic fibrosis.